Status:
COMPLETED
Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery
Lead Sponsor:
University of Luebeck
Conditions:
Idiopathic Macular Hole
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To evaluate the anatomical and visual outcomes after vitrectomy and internal limiting membrane (ILM) peeling with indocyanine green (ICG) or trypan blue (TB) for idiopathic macular hole repair in a pr...
Detailed Description
In several clinical trials the positive effect of inner limiting membrane peeling (ILM) on anatomical and functional outcome in macular hole surgery has been reported. Controversies, however, exist re...
Eligibility Criteria
Inclusion
- Patients with idiopathic macular holes stage II-IV according to the classification proposed by Gass and a visual acuity of at least 20/200 entered this study.
Exclusion
- Patients with secondary macular holes, previous intraocular surgery, except for uneventful cataract extraction and patients with ocular disorders that might interfere with vision such as severe cataract, exudative age-related macular degeneration or diabetic retinopathy.
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00419185
Start Date
April 1 2003
End Date
January 1 2005
Last Update
January 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Clinic, University Schleswig-Holstein, Campus Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538